ArticleFrontiers in tuberculosis2026
Non-tuberculous mycobacteria pulmonary disease in Texas: an analysis of 8 years of hospital discharge data.
Article in Frontiers in tuberculosis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Non-tuberculous mycobacterial (NTM) pulmonary disease (PD) is a recognized chronic condition associated with high healthcare utilization. Texas statewide NTM diagnosis-coded inpatient discharges per 100,000 discharge records (healthcare utilization) have not been systematically studied. Methods: We analyzed Texas hospital inpatient discharge public use data between 2016 and 2023 for all 254 Texas counties. MS-EXCEL and SPSS were used for data collection and analysis. Results: Out of 23.33 million hospital discharge records, 12,587 were identified to have an NTM diagnosis-coded inpatient discharge. Among the patients with NTM, 3.3% of the patients were aged 0-17 years, 19.5% were 18-44 years, 29.5% were 45-64 years, and 47.7% were 65 + years old. The NTM diagnosis-coded inpatient discharge rate in Texas was calculated to be 59.9/100,000 records (range 46.1-62.6). A total of 815 NTM cases were reported in Northeast Texas and 4,203 cases in the Gulf Coast counties. The total number of in-hospital deaths among the NTM-coded discharges was 692 (5.5% of total NTM cases). The number of patients with NTM covered under Medicare Part A was 5,102 and 1,521 were on Medicaid. Conclusions: Based on the hospital discharge data analysis, there appears to be regional variation in the prevalence of NTM disease in Texas. Further studies are needed to determine these variations and to improve our understanding of NTM-PD in Texas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.